Xeris Biopharma Holdings
XERS
XERS
200 hedge funds and large institutions have $423M invested in Xeris Biopharma Holdings in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 199 → 200 (+1)
11% less capital invested
Capital invested by funds: $477M → $423M (-$54M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
200
Holding in Top 10
2
Calls
$1.02M
Puts
$384K
Top Buyers
| 1 | +$7.97M | |
| 2 | +$5.82M | |
| 3 | +$5.24M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.66M |
| 5 |
BlackRock
New York
|
+$3.46M |
Top Sellers
| 1 | -$7.4M | |
| 2 | -$5.06M | |
| 3 | -$4.39M | |
| 4 |
Jane Street
New York
|
-$3.68M |
| 5 |
Morgan Stanley
New York
|
-$3.02M |
